Becton Dickinson & Co (BDX)

BDX (NYSE:Health Services)
pos +1.18
Today's Range: 127.87 - 129.34 | BDX Avg Daily Volume: 1,344,000
Last Update: 10/31/14 - 4:02 PM EDT
Volume: 1,320,892
YTD Performance: 15.41%
Open: $129.34
Previous Close: $127.52
52 Week Range: $104.60 - $130.21
Oustanding Shares: 191,835,949
Market Cap: 24,319,043,255
6-Month Chart
TheStreet Ratings Grade for BDX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 5 5 6
Moderate Buy 0 0 0 0
Hold 8 8 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 1 2 2
Mean Rec. 2.14 2.43 2.57 2.47
Latest Dividend: 0.54
Latest Dividend Yield: 1.72%
Dividend Ex-Date: 09/05/14
Price Earnings Ratio: 25.71
Price Earnings Comparisons:
BDX Sector Avg. S&P 500
25.71 25.70 26.77
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.82% 20.70% 60.12%
Revenue 4.50 0.09 0.03
Net Income 10.50 -0.21 -0.07
EPS 16.30 0.18 0.06
Earnings for BDX:
Revenue 8.05B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (09/14) FY (09/15)
Average Estimate $1.65 $1.52 $6.24 $6.70
Number of Analysts 9 5 13 11
High Estimate $1.67 $1.57 $6.29 $6.86
Low Estimate $1.62 $1.41 $6.20 $6.40
Prior Year $1.58 $1.42 $5.95 $6.24
Growth Rate (Year over Year) 4.64% 6.76% 4.89% 7.36%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Hospitals, biotechs and drug makers continue to hold their own.
There may be a wave of consolidation.
The miners are untouchable.
Oct 07, 2014 | 7:11 AM EDT
BDX was upgraded from Hold to Buy, Stifel Nicolaus said. $153 price target. Carefusion deal makes both financial and strategic sense.
Whatever you pick, it is hard to keep up with the S&P 500.

This Morning's Market Setup Real Money Pro($)

Where it began.
Oct 06, 2014 | 7:48 AM EDT
BDX was upgraded from Underweight to Neutral, JP Morgan said. $134 price target. Carefusion deal will add to earnings. 
A wave of M&A in the health sector makes sense.
If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.
Jan 21, 2014 | 8:14 AM EST
BSX was upgraded to Overweight, Piper Jaffray said. $18 price target. Company is in the second leg of a multi-year move. 

Columnist Conversations

Conclusion This is a very quick note to visualize the solar stock peer group. I'll do some individual stories ...
Conclusion SSYS is one of two giants in the 3-D printing arena and is reporting earnings on November 5th, afte...
Market continues to hold onto impressive gains in the last day of a roller coaster trading month. This month ...
UPS is bumping up against a very heavy layer of resistance today. The stock's 1.6% gain has pushed shar...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.